Literature DB >> 24624284

Aspergilloma and the surgeon.

Loven Moodley1, Jehron Pillay1, Keertan Dheda1.   

Abstract

Aspergillus fungus is a ubiquitous saprophyte that is the causative organism for the development of an aspergilloma. The most common species causing an aspergilloma is the Apergillus fumigatus. An aspergilloma is a conglomeration of mucus, inflammatory cells and altered blood elements. Aspergillomas typically form in pre-existing lung pathology, most notably and commonly in old healed tuberculosis cavities. They are classified into simple and complex types that have clinical relevance. Symptoms are very variable and it is not uncommon to incidentally find a lung aspergilloma. In most case series, the most common presenting symptom is haemoptysis which varies from mild to catastrophic bleeds. Given the limited information about the natural history of the disease, there is unfortunately no recognised factor or variable which can predict how an aspergilloma will manifest itself, hence the manner of treatment is a still a topic of debate among treating physicians. The mainstay of treatment is surgical intervention and medical options although disappointing at the current stage, require further investigation in light of the newer available anti-fungal agents. The need for surgical intervention is however not as clear-cut as one would like, since many patients have multiple co-morbidities and other diffuse or focal lung pathology, making the decision process indeterminate in certain instances. In this review, we focus on the different surgical options available for the management of aspergilloma across variable clinical settings, and we propose an approach to its management.

Entities:  

Keywords:  Aspergilloma; clinical course; surgical management

Year:  2014        PMID: 24624284      PMCID: PMC3949189          DOI: 10.3978/j.issn.2072-1439.2013.12.40

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  38 in total

1.  An unusual pulmonary cavitating lesion.

Authors:  E Lachanas; P Tomos; M Fotinou; K Kalokerinou
Journal:  Respiration       Date:  2005-07-21       Impact factor: 3.580

2.  Pulmonary aspergillosis: an analysis of 41 patients.

Authors:  A Karas; J R Hankins; S Attar; J E Miller; J S McLaughlin
Journal:  Ann Thorac Surg       Date:  1976-07       Impact factor: 4.330

3.  Indications and outcome of surgery for pulmonary aspergilloma.

Authors:  R el Oakley; M Petrou; P Goldstraw
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

4.  Surgical treatment for pulmonary aspergilloma: a 28 year experience.

Authors:  J C Chen; Y L Chang; S P Luh; J M Lee; Y C Lee
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

5.  Operation for cavitating invasive pulmonary aspergillosis in immunocompromised patients.

Authors:  V K Young; H A Maghur; D A Luke; E M McGovern
Journal:  Ann Thorac Surg       Date:  1992-04       Impact factor: 4.330

6.  Pulmonary calcification in the tumor-like form of pulmonary aspergillosis:pulmonary aspergilloma.

Authors:  J C Pimentel
Journal:  Am Rev Respir Dis       Date:  1966-08

7.  Surgical treatment of pulmonary aspergilloma.

Authors:  Raul Lopes Ruiz Júnior; Frederico Henrique Sobral de Oliveira; Bruno Luiz Burgos Piotto; Felipe Antunes e Silva de Souza Lopes Muniz; Daniele Cristina Cataneo; Antonio José Maria Cataneo
Journal:  J Bras Pneumol       Date:  2010 Nov-Dec       Impact factor: 2.624

8.  Pulmonary aspergilloma: analysis of prognosis in relation to symptoms and treatment.

Authors:  Jin Gu Lee; Chang Young Lee; In Kyu Park; Dae Joon Kim; Joon Chang; Se Kyu Kim; Kyung Young Chung
Journal:  J Thorac Cardiovasc Surg       Date:  2009-04-11       Impact factor: 5.209

9.  Surgical outcome of pulmonary aspergilloma.

Authors:  Alaa Brik; Abdel Meged Salem; Al Rady Kamal; Mohamed Abdel-Sadek; Mohamed Essa; Mamdoh El Sharawy; Ahmed Deebes; Khaled Abdel Bary
Journal:  Eur J Cardiothorac Surg       Date:  2008-08-12       Impact factor: 4.191

10.  Pulmonary aspergilloma: a treatment challenge in sub-Saharan Africa.

Authors:  Christian Pohl; Levan Jugheli; Fredrick Haraka; Elirehema Mfinanga; Khadija Said; Klaus Reither
Journal:  PLoS Negl Trop Dis       Date:  2013-10-24
View more
  13 in total

1.  Two cases of endobronchial aspergilloma with lung cancer: a review the literature of endobronchial aspergilloma with underlying malignant lesions of the lung.

Authors:  Shenghua Jiang; Luning Jiang; Fenglian Shan; Xiulian Zhang; Ming Song
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  Surgical management of non-mycobacterial fungal infections.

Authors:  Staci Beamer
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

3.  Risk factors of severe hemoptysis in patients with fungus ball.

Authors:  Tae Hoon Kim; Hyun Jung Koo; Chae-Man Lim; Sang-Bum Hong; Jin Won Huh; Kyung Wook Jo; Tae Sun Shim; Woo Sung Kim; Younsuck Koh
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

4.  Is adjuvant antifungal therapy after video-assisted thoracic surgery for pulmonary aspergilloma necessary?

Authors:  Shuo Zheng; Xin Li; Bin Hu; Hui Li
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

5.  Post-tuberculosis mycetoma: bronchoscopic removal.

Authors:  Liam J Chawke; Eoin B Hunt; Marcus P Kennedy; Desmond M Murphy
Journal:  Respirol Case Rep       Date:  2017-06-01

6.  Complex Pulmonary Aspergilloma: Surgical Challenges in a Third World Setting.

Authors:  Bernadette Ngo Nonga; Guy Aristide Bang; Bonaventure Jemea; Eric Savom; Perfura Yone; Ngahane Mbatchou; Jean Jacques Ze
Journal:  Surg Res Pract       Date:  2018-01-14

7.  Surgical treatment of chronic pulmonary aspergillosis using preventive latissimus dorsi muscle flaps.

Authors:  Yoshinobu Hata; Hajime Otsuka; Takashi Makino; Satoshi Koezuka; Keishi Sugino; Nobuyuki Shiraga; Naobumi Tochigi; Kazutoshi Shibuya; Sakae Homma; Akira Iyoda
Journal:  J Cardiothorac Surg       Date:  2015-11-05       Impact factor: 1.637

8.  Cystic Bronchiectasis Imitating Pulmonary Aspergilloma.

Authors:  Hong-Xia Shao; Hui Ning; Li Li; Qi Wu; Yong-Mei Wang; Zhi-Heng Xing; Cheng-Zhi Wang
Journal:  Chin Med J (Engl)       Date:  2016-09-05       Impact factor: 2.628

9.  Successful Long-term Management of Two Cases of Moderate Hemoptysis Due to Chronic Cavitary Pulmonary Aspergillosis with Bronchial Occlusion Using Silicone Spigots.

Authors:  Naohiro Oda; Makoto Sakugawa; Shinobu Hosokawa; Nobuaki Fukamatsu; Akihiro Bessho
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

Review 10.  [Infectious pulmonary diseases].

Authors:  T Hager; H Reis; D Theegarten
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.